|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.027 HKD | +3.85% |
|
+17.39% | -50.91% |
| Mar. 28 | China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 15 | China NT Pharma Group Company Limited Announces Directorate Changes | CI |
China NT Pharma Group Company Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 207.09 million compared to CNY 226.7 million a year ago. Net loss was CNY 66.41 million compared to CNY 149.54 million a year ago.
Basic loss per share from continuing operations was CNY 0.035 compared to CNY 0.0791 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -50.91% | 8.77M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
CHINA NT PHARMA GROUP COMPANY LIMITED 
